News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Coiante Scott M
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/04/2023 |
4
| Coiante Scott M (CFO) has filed a Form 4 on AGILE THERAPEUTICS INC|
Txns:
| Granted 20,000 shares
@ $0 |
|
| 08/01/2022 |
4
| Coiante Scott M (SVP, CFO) has filed a Form 4 on Aprea Therapeutics, Inc.|
Txns:
| Granted 60,800 shares
@ $0
Granted 89,200 options to buy
@ $1.09, valued at
$97.2k
|
|
| 06/07/2022 |
4
| Coiante Scott M (SVP, CFO) has filed a Form 4 on Aprea Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 35,284 shares
@ $0.805, valued at
$28.4k
|
|
| 03/14/2022 |
4
| Coiante Scott M (SVP, CFO) has filed a Form 4 on Aprea Therapeutics, Inc.|
Txns:
| Granted 42,900 shares
@ $0
Granted 185,900 options to buy
@ $1.82, valued at
$338.3k
|
|
| 03/01/2022 |
4
| Coiante Scott M (SVP, CFO) has filed a Form 4 on Aprea Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 14,817 shares
@ $1.74, valued at
$25.8k
|
|
| 08/27/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/01/2021 |
4
| Coiante Scott M (SVP, CFO) has filed a Form 4 on Aprea Therapeutics, Inc.|
Txns:
| Granted 33,000 shares
@ $0
Granted 63,500 shares
@ $0
Granted 143,000 options to buy
@ $6, valued at
$858k
|
|
| 03/26/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/07/2019 |
4
| Coiante Scott M (SVP, CFO) has filed a Form 4 on Aprea Therapeutics, Inc.|
Txns:
| Bought 2,500 shares
@ $15, valued at
$37.5k
Granted 150,824 options to buy
@ $15, valued at
$2.3M
|
|
| 01/31/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/28/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2018 |
4
| Coiante Scott M (CFO) has filed a Form 4 on AGILE THERAPEUTICS INC|
Txns:
| Granted 150,000 options to buy
@ $0.58, valued at
$87k
|
|
| 01/26/2018 |
4
| Coiante Scott M (CFO) has filed a Form 4 on AGILE THERAPEUTICS INC|
Txns:
| Paid exercise price by delivering 6,753 shares
@ $3.32, valued at
$22.4k
Granted 107,000 options to buy
@ $3.46, valued at
$370.2k
Granted 16,070 restricted stock units
@ $0
Exercised 17,500 restricted stock units
@ $0 |
|
| 01/27/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/10/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|